Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it will participate at the upcoming 21st Annual Needham Virtual Healthcare Conference.
ATLANTA, March 31, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the upcoming 21st Annual Needham Virtual Healthcare Conference. The Company’s virtual fireside chat is scheduled to begin at 9:30 a.m. ET on Thursday, April 14, 2022.
A live webcast of the virtual fireside chat will be accessible through Artivion’s website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with aortic diseases. Artivion’s four major groups of products include: aortic stents and stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.
| Artivion | Gilmartin Group LLC |
| D. Ashley Lee | Brian Johnston / Lynn Lewis |
| Executive Vice President & | Phone: 332-895-3222 |
| Chief Financial Officer | |
| Phone: 770-419-3355 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-the-21st-annual-needham-virtual-healthcare-conference-301514629.html
SOURCE Artivion, Inc.
Company Codes: NYSE:AORT
